Free Trial
NASDAQ:DRTS

Alpha Tau Medical Q4 2024 Earnings Report

Alpha Tau Medical logo
$3.36 -0.01 (-0.30%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$3.26 -0.10 (-2.95%)
As of 08/28/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alpha Tau Medical EPS Results

Actual EPS
-$0.13
Consensus EPS
-$0.13
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Alpha Tau Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Alpha Tau Medical Announcement Details

Quarter
Q4 2024
Time
After Market Closes
Conference Call Date
Wednesday, March 12, 2025
Conference Call Time
4:00PM ET

Alpha Tau Medical Earnings Headlines

Alpha Tau to Participate in Five September Investor Conferences
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.tc pixel
Alpha Tau Medical Ltd. (DRTS) - Yahoo Finance
See More Alpha Tau Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Alpha Tau Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alpha Tau Medical and other key companies, straight to your email.

About Alpha Tau Medical

Alpha Tau Medical (NASDAQ:DRTS), a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

View Alpha Tau Medical Profile

More Earnings Resources from MarketBeat